Paris, France

Mayalen Oxoby

This inventor holds 7 USPTO granted patents and 3 EPO patents. Top assignees: Fab Pharma S.a.s., Laboratoire Biodim. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayalen Oxoby. Retrieved from https://idiyas.com/inventor/mayalen-oxoby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Mayalen Oxoby: Innovator in Pharmaceutical Compounds

Introduction

Mayalen Oxoby is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. Her work focuses on developing novel compounds that have potential applications in medicine.

Latest Patents

Among her latest patents is the invention titled "Heterocyclic acrylamides and their use as pharmaceuticals." This invention relates to novel heterocyclic acrylamide compounds, detailing their preparation and use as antibacterial medicaments. Another notable patent is for an "Antibacterial hydroxyphenyl compound," which describes a new hydroxyphenyl compound and its application as an antibacterial medicament.

Career Highlights

Throughout her career, Mayalen has worked with various companies, including Fab Pharma S.a.s. and Laboratoire Biodim. Her innovative work has positioned her as a key figure in the pharmaceutical industry.

Collaborations

Mayalen has collaborated with several professionals in her field, including Vincent Gerusz and Sonia Escaich. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Mayalen Oxoby's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her patents reflect her commitment to developing effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…